LIA
NKTR icon

LS Investment Advisors’s Nektar Therapeutics NKTR Stock Holding History

LS Investment Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-669
Closed -$171K – 863
2020
Q4 		$171K Hold
669
– – 0.01% 841
2020
Q3 		$166K Hold
669
– – 0.01% 731
2020
Q2 		$232K Buy
669
+27
+4% +$8.43K 0.01% 663
2020
Q1 		$172K Hold
642
– – 0.01% 686
2019
Q4 		$208K Sell
642
-172
-21% -$49.9K 0.01% 789
2019
Q3 		$223K Buy
814
+261
+47% +$95.7K 0.01% 735
2019
Q2 		$295K Hold
553
– – 0.02% 630
2019
Q1 		$279K Buy
553
+15
+3% +$8.89K 0.02% 655
2018
Q4 		$265K Buy
538
+13
+2% +$7.85K 0.02% 645
2018
Q3 		$480K Sell
525
-13
-2% -$11.1K 0.03% 514
2018
Q2 		$394K Buy
538
+175
+48% +$202K 0.02% 598
2018
Q1 		$578K Sell
363
-47
-11% -$60.6K 0.03% 445
2017
Q4 		$367K Buy
410
+29
+8% +$17.2K 0.02% 633
2017
Q3 		$137K Sell
381
-59
-13% -$18.5K 0.01% 1065
2017
Q2 		$129K Buy
440
+36
+9% +$10.4K 0.01% 1056
2017
Q1 		$142K Sell
404
-21
-5% -$4.72K 0.01% 993
2016
Q4 		$78K Buy
425
+41
+11% +$8.34K 0.01% 1120
2016
Q3 		$99K Buy
384
+7
+2% +$1.8K 0.01% 1009
2016
Q2 		$81K Buy
377
+16
+4% +$3.58K 0.01% 1051
2016
Q1 		$74K Buy
361
+33
+10% +$6.34K 0.01% 995
2015
Q4 		$83K Sell
328
-8
-2% -$1.65K 0.01% 935
2015
Q3 		$55K Hold
336
– – ﹤0.01% 1097
2015
Q2 		$63K Buy
+336
New +$57.8K ﹤0.01% 1076

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

LS Investment Advisors's NKTR Position: Q1 2021 in Review

LS Investment Advisors sold out of Nektar Therapeutics (NKTR) in Q1 2021, closing a stake of 669 shares — an estimated $171K sold.

LS Investment Advisors first reported a position in NKTR in Q2 2015 and held it in 23 quarters. The position peaked at $578K in Q1 2018. 235 funds tracked by Wall St. Rank hold NKTR as of Q1 2021.

  • LS Investment Advisors reported no remaining Nektar Therapeutics position as of Q1 2021 after selling out during the quarter.
  • LS Investment Advisors sold 669 Nektar Therapeutics shares in Q1 2021, an estimated $171K.
  • LS Investment Advisors first reported a position in Nektar Therapeutics in Q2 2015 and held it in 23 quarters.
  • LS Investment Advisors's Nektar Therapeutics position peaked at $578K in Q1 2018.
  • 235 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2021.

Based on LS Investment Advisors's 13F filing for Q1 2021, filed 13 May 2021.